Detailed molecular characterisation of acute myeloid leukaemia with a normal karyotype using targeted DNA capture
Nathalie Conte(European Bioinformatics Institute), George S. Vassiliou(Wellcome/MRC Cambridge Stem Cell Institute), Brian J.P. Huntly(Wellcome/MRC Cambridge Stem Cell Institute), Paul Costeas(Deakin University), Thaidy Moreno-Rodriguez(Instituto de Biomedicina y Biotecnología de Cantabria), Bram Herman(Agilent Technologies (United Kingdom)), Carolyn Grove(The University of Western Australia), Niccolò Bolli(University of Milan), Dania Haddad(Dasman Diabetes Institute), Mike Scott(Addenbrooke's Hospital), Peter Ellis(Oldham Council), Ignacio Varela(Wellcome Sanger Institute), Emma Gudgin(University of Cambridge), Allan Bradley(Granta Design (United Kingdom)), Roland Rad(ING Direct), Anthony J. Bench(Addenbrooke's Hospital), Kosuke Yusa(Kyoto University), Anne Segonds-Pichon(Babraham Institute), Nicla Manes(Wellcome Sanger Institute)
Cited by 29
Related Papers
Signatures of mutational processes in human cancer
|Nature|2013|10.1k
Genomic Classification and Prognosis in Acute Myeloid Leukemia
|New England Journal of Medicine|2016|4.4k
Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders
|The Lancet|2005|3.4k